Paper Details

  1. Home
  2. Paper Details

Intravesical gentamicin for recurrent urinary tract infection in patients with intermittent bladder catheterisation.

Author: ElzevierH W, den ExterP L, den HartighJ, van DisselJ T, van NieuwkoopC

Case ReportsIn the medical field, a report that describes in detail a unique case, an unusual medical condition, or the effect of a treatment. Provides new insights and possibilities for treatment through individual patient cases.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

This study investigated the efficacy and safety of intravesical gentamicin treatment for recurrent urinary tract infections (UTIs) in patients using clean intermittent catheterization (CIC). The study found that intravesical gentamicin was effective in two patients, with no reported side effects. However, the authors acknowledge the limited data and call for further research to confirm its effectiveness and safety.
Paper Details　
Original Abstract of the Article :
Clean intermittent catheterisation (CIC) of the bladder is used to imitate normal bladder emptying in patients with bladder dysfunction. CIC is associated with urinary tract infection (UTI) that may be difficult to treat in the case of antimicrobial resistance. The aim of this study was to establish...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.ijantimicag.2010.05.005

データ提供：米国国立医学図書館（NLM）

Intravesical Gentamicin: A New Oasis for Recurrent UTIs

The management of [urinary tract infections (UTIs)] in patients with [bladder dysfunction] can be a challenging endeavor. This study, like a skilled physician navigating a complex medical case, explores the efficacy and safety of intravesical gentamicin treatment for recurrent UTIs in patients using clean intermittent catheterization (CIC).

The researchers, meticulously analyzing data from two patients with recurrent UTIs caused by multiresistant Escherichia coli, discovered that intravesical gentamicin treatment effectively resolved their symptoms and resulted in negative urine cultures. This finding, like a shimmering oasis in a parched desert, offers a potential solution for patients struggling with recurrent UTIs, particularly those with antibiotic-resistant bacteria.

Furthermore, the study found no significant side effects associated with intravesical gentamicin treatment. This discovery, like a safe passage through a treacherous desert, underscores the potential of this treatment approach for managing recurrent UTIs.

Navigating the Challenges of UTIs: A New Approach to Treatment

This study, like a compass guiding us through the complexities of UTIs, highlights the potential of intravesical gentamicin as a promising treatment option. This research, like a well-paved road, offers a new pathway for managing recurrent UTIs, particularly in patients with antibiotic-resistant infections.

A Future of Innovation: Exploring New Frontiers in UTI Treatment

The study underscores the importance of ongoing research and development in the field of UTI treatment. This continuous journey, like a caravan traversing a vast desert, seeks to improve the lives of patients by developing safer and more effective therapies.

Dr.Camel's Conclusion

This study, like a well-traveled road through a vast desert, reminds us that the search for effective treatments for UTIs is an ongoing journey. By exploring the potential of intravesical gentamicin and other innovative therapies, we can hope for a future where UTIs can be effectively managed and those affected can experience improved outcomes and a better quality of life.

Date :
  1. Date Completed 2011-02-25
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

20580533

DOI: Digital Object Identifier

10.1016/j.ijantimicag.2010.05.005

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.